{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:22:26Z","timestamp":1792030946752,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11606-019-05030-6","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T22:20:44Z","timestamp":1559600444000},"page":"1554-1563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Prescription Medications for the Treatment of Insomnia and Risk of Suicide Attempt: a Comparative Safety Study"],"prefix":"10.1007","volume":"34","author":[{"given":"Jill E.","family":"Lavigne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan","family":"Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred R.","family":"Pigeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"issue":"6","key":"5030_CR1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/sleep\/31.6.881","volume":"31","author":"M Jansson-Frojmark","year":"2008","unstructured":"Jansson-Frojmark M, Linton SJ. The course of insomnia over one year: a longitudinal study in the general population of Sweden. Sleep. 2008;31(6):881\u2013886.","journal-title":"Sleep."},{"issue":"9","key":"5030_CR2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.sleep.2009.07.008","volume":"10","author":"MM Ohayon","year":"2009","unstructured":"Ohayon MM, Reynolds CF. Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification Sleep Disorders (ICSD). Sleep Med. 2009;10(9):952\u2013960.","journal-title":"Sleep Med."},{"issue":"9","key":"5030_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.sleep.2013.05.003","volume":"14","author":"CM Morin","year":"2013","unstructured":"Morin CM, Jarrin DC. Insomnia and healthcare-seeking behaviors: impact of case definitions, comorbidity, sociodemographic, and cultural factors. Sleep Med. 2013;14(9):808\u2013809.","journal-title":"Sleep Med."},{"issue":"5","key":"5030_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.5665\/sleep.1832","volume":"35","author":"J Fernandez-Mendoza","year":"2012","unstructured":"Fernandez-Mendoza J, Vgontzas AN, Bixler EO, et al. Clinical and polysomnographic predictors of the natural history of poor sleep in the general population. Sleep. 2012;35(5):689\u2013697.","journal-title":"Sleep."},{"issue":"0","key":"5030_CR5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/sleep\/32.9.1221","volume":"32","author":"JM Kim","year":"2009","unstructured":"Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS. Insomnia, depression, and physical disorder in late life: a 2-year longitudinal community study in Koreans. Sleep. 2009;32(0):1221\u20131228.","journal-title":"Sleep."},{"issue":"1","key":"5030_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2046-4053-3-18","volume":"3","author":"S Malik","year":"2014","unstructured":"Malik S, Kanwar A, Sim LA, et al. The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis. Syst Rev. 2014;3(1):18.","journal-title":"Syst Rev."},{"issue":"9","key":"5030_CR7","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.4088\/JCP.11r07586","volume":"73","author":"WR Pigeon","year":"2012","unstructured":"Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry. 2012;73(9):1160\u20131167.","journal-title":"J Clin Psychiatry."},{"issue":"3","key":"5030_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3928\/00485713-20160128-01","volume":"46","author":"WR Pigeon","year":"2016","unstructured":"Pigeon WR, Bishop TM, Titus, CE. The relationship of sleep disturbance to suicidal ideation, suicide attempts and suicide among adults: a systematic review. Psychiatr Ann. 2016;46(3):177\u2013186.","journal-title":"Psychiatr Ann."},{"issue":"3","key":"5030_CR9","first-page":"157","volume":"3","author":"JE Lavigne","year":"2012","unstructured":"Lavigne JE, Au A, Jiang R, et al. Utilization of prescription drugs with warnings of suicidal thoughts and behaviours in the USA and the US Department of Veterans Affairs, 2009. J Pharm HSR. 2012;3(3):157\u2013163.","journal-title":"J Pharm HSR."},{"issue":"11","key":"5030_CR10","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"The American Geriatrics Society 2015 Beers Criteria Update Expert Panel","year":"2015","unstructured":"The American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;63(11):2227\u20132246.","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"5030_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/14034940210167966","volume":"31","author":"A Carlsten","year":"2003","unstructured":"Carlsten A, Waern M, Holmgren P, Allebeck P. The role of benzodiazepines in elderly suicides. Scand J Public Health. 2003;31(3):224\u2013228.","journal-title":"Scand J Public Health."},{"issue":"4","key":"5030_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4088\/JCP.09m05484gry","volume":"72","author":"KJ Brower","year":"2011","unstructured":"Brower KJ, McCammon RJ, Wojnar M, Ilgen MA, Wojnar J, Valenstein M. Prescription sleeping pills, insomnia, and suicidality in the National Comorbidity Survey Replication. J Clin Psychiatry. 2011;72(4):515\u2013521.","journal-title":"J Clin Psychiatry."},{"issue":"2","key":"5030_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/13811118.2013.824837","volume":"18","author":"WR Pigeon","year":"2014","unstructured":"Pigeon WR, Woosley JA, Lichstein KL. Insomnia and hypnotic medications are associated with suicidal ideation in a community population. Arch Suicide Res. 2014;18(2):170\u2013180.","journal-title":"Arch Suicide Res."},{"key":"5030_CR14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0006-3223(97)00292-8","volume":"43","author":"DF Kripke","year":"1998","unstructured":"Kripke DF, Klauber MR, Wingard DL, et al. Mortality hazard associated with prescription hypnotics. Biol Psychiatry. 1998;43:687\u2013693.","journal-title":"Biol Psychiatry."},{"key":"5030_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00006842-199101000-00009","volume":"53","author":"C Allgulander","year":"1991","unstructured":"Allgulander C, N\u00e4sman P. Regular hypnotic drug treatment in a sample of 32,679 Swedes: associations with somatic and mental health, inpatient psychiatric diagnoses, and suicide, derived with automated record-linkage. Psychosom Med. 1991;53:101\u2013108","journal-title":"Psychosom Med."},{"key":"5030_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.sleep.2008.12.004","volume":"10","author":"L Mallon","year":"2009","unstructured":"Mallon L, Broman J-E, Hetta J. Is usage of hypnotics associated with mortality? Sleep Med. 2009; 10:279\u2013286","journal-title":"Sleep Med."},{"issue":"2","key":"5030_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","volume":"13","author":"MJ Sateia","year":"2017","unstructured":"Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017, 13(2):307\u201349.","journal-title":"J Clin Sleep Med."},{"issue":"2","key":"5030_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5665\/sleep.3410","volume":"37","author":"SM Bertisch","year":"2014","unstructured":"Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014;37(2):343\u2013349.","journal-title":"Sleep."},{"issue":"2","key":"5030_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/NMD.0000000000000657","volume":"205","author":"MA Greenbaum","year":"2017","unstructured":"Greenbaum MA, Neylan TC, Rosen CS. Symptom presentation and prescription of sleep medication for veterans with Posttraumatic Stress Disorder. J Nerv Ment Dis. 2017;205(2):112\u2013118.","journal-title":"J Nerv Ment Dis."},{"issue":"1","key":"5030_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1176\/appi.ajp.2016.16030336","volume":"174","author":"WV McCall","year":"2017","unstructured":"McCall WV, Benca RM, Rosenquist PB, et al. Hypnotic medications and suicide: risk, mechanism, mitigation, and the FDA. Am J Psychiatry. 2017;174(1):18\u201325.","journal-title":"Am J Psychiatry."},{"issue":"6","key":"5030_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1177\/0033354916670133","volume":"131","author":"C Hoffmire","year":"2016","unstructured":"Hoffmire C, Stephens B, Morley S, Thompson C, Kemp J, Bossarte R. VA Suicide Prevention Applications Network: a national health care system-based suicide event tracking system. Public Health Rep. 2016;131(6):816\u2013821.","journal-title":"Public Health Rep."},{"key":"5030_CR22","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s11606-015-3220-y","volume":"30","author":"JJ Im","year":"2015","unstructured":"Im JJ, Schachter, Schacter RD, Oliva EM, Henderson PT, Paik MC, Trafton JA, for the PROGRES Team. Association of care practices with suicide attempts in US Veterans prescribed opioid medications for chronic pain management. J Gen Intern Med. (2015) 30: 979. \n                    https:\/\/doi.org\/10.1007\/s11606-015-3220-y\n                    \n                  .","journal-title":"J Gen Intern Med."},{"issue":"2","key":"5030_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150\u201361.","journal-title":"Pharm Stat."},{"issue":"3","key":"5030_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res."},{"issue":"4","key":"5030_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4088\/JCP.v66n0409","volume":"66","author":"WB Mendelson","year":"2005","unstructured":"Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469\u2013476.","journal-title":"J Clin Psychiatry."},{"issue":"6","key":"5030_CR26","doi-asserted-by":"publisher","first-page":"752","DOI":"10.4088\/JCP.v65n0605","volume":"65","author":"SP James","year":"2004","unstructured":"James SP, Mendelson WB. The use of trazodone as a hypnotic: a critical review. J Clin Psychiatry. 2004;65(6):752\u2013755.","journal-title":"J Clin Psychiatry."},{"issue":"1","key":"5030_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/JCP.0000000000000831","volume":"38","author":"DJ Greenblatt","year":"2018","unstructured":"Greenblatt DJ, Harmatz JS, Shader RI. Update on psychotropic drug prescribing in the United States: 2014\u20132015. J Clin Psychopharmacol. 2018;38(1):1\u20134","journal-title":"J Clin Psychopharmacol."},{"issue":"11","key":"5030_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1176\/appi.ajp.2016.15070854","volume":"173","author":"JM Bostwick","year":"2016","unstructured":"Bostwick JM, Pabbati C, Geske JR, McKean AJ. Suicide attempt as a risk factor for completed suicide: even more lethal than we knew. Am J Psychiatry. 2016;173(11):1094\u2013100.","journal-title":"Am J Psychiatry."},{"issue":"11","key":"5030_CR29","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/0269881110379307","volume":"24","author":"SJ Wilson","year":"2010","unstructured":"Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24(11):1577\u20131601.","journal-title":"J Psychopharmacol."},{"issue":"2","key":"5030_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/M15-2175","volume":"165","author":"A Quaseem","year":"2016","unstructured":"Quaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125\u2013133.","journal-title":"Ann Intern Med."},{"key":"5030_CR31","unstructured":"VISN 22 Insomnia Guidance. [Last updated 12\/14\/12]. Last accessed 3\/8\/19 from: \n                    http:\/\/vaww.gla.med.va.gov\/Pharmacy\/Guidelines\/insomnia.htm"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-05030-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-019-05030-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-019-05030-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:06:19Z","timestamp":1591142779000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-019-05030-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["5030"],"URL":"https:\/\/doi.org\/10.1007\/s11606-019-05030-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the VA VISN2 (Syracuse VA) Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Pigeon received speaker fees from Merck in 2015. All other authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors\u2019 views or opinions do not necessarily represent those of the Department of Veterans Affairs or the United States Government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}